Literature DB >> 26667788

FGFR1 and KAT6A rearrangements in patients with hematological malignancies and chromosome 8p11 abnormalities: biological and clinical features.

Carmen Baldazzi1, Simona Luatti1, Stefania Paolini1, Cristina Papayannidis1, Giulia Marzocchi1, Gaia Ameli1, Giovanni Martinelli1, Michele Cavo1, Nicoletta Testoni1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26667788     DOI: 10.1002/ajh.24276

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  1 in total

1.  Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and CEP110-FGFR1 Rearrangement.

Authors:  Marc Wehrli; Elisabeth Oppliger Leibundgut; Heinrich H Gattiker; Markus G Manz; Antonia M S Müller; Jeroen S Goede
Journal:  Oncologist       Date:  2017-02-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.